Abstract View

Author(s): Shaikh Shoeb1, Mohammad Huzaifa2, Bagwan Saman3

Email(s): 1shaikhshoeb4440@gmail.com

Address:

    Ali Allana College of Pharmacy, Akkalkuwa (M.S.) India

Published In:   Volume - 3,      Issue - 3,     Year - 2024

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Nigella sativa (N. sativa) (Family Ranunculaceae) has been used as a curative remedy for thousands of years. N. sativa seed exhibits a wide range of pharmacological activities, including immunopotentiation, antihistaminic, anti-hypertensive, anti-inflammatory, and antimicrobial properties. It contains thymoquinone, thymohydroquinone, dithymoquinone, p-cymene, carvacrol, 4-terpineol, t-anethol, sesquiterpene longifolene, nigellicimine and nigellicimine-N-oxide, -pinene, and thymol, among other things. The incalculable medicinal properties and therapeutic applications of N. sativa demonstrate its value as a valuable medicinal plant. The goal of this review is to summarize some important pharmacological studies and phytochemical investigations on N. sativa and isolated principles that can be further investigated in the search for novel molecules in the search for novel herbal drugs.

Cite this article:
Shaikh Shoeb*, Mohammad Huzaifa, Bagwan Saman. A Comprehensive Review of Black Cumin. IJRPAS, May-June 2024; 3(3): 146-153.


1.      Zohary, D. And Hopf, M. 2000. Domestication of plants in the old world (3rd Ed.). Oxford University Press. pp. 206. ISBN: 0198503563. [bcar]

2.      Malhotra, S. K. and Vashishtha, B. B. 2008. Response of nigella (Nigella sativa L) variety NRCSS AN 1 to different agro-tech- niques. J. Spices Aromatic Crops 17: 190-193.

3.      Khare CP. Encyclopedia of Indian medicinal plants. NewYork Springes-Verlag Berlin Heidelberg, 2004. 

4.      S. Javed, A. A. Shahid, and M. S. Haider, “Nutritional, phytochemical potential and pharmacological evaluation of Nigella Sativa (Kalonji) and Trachyspermum Ammi (Ajwain),” Journal of Medicinal Plants Research, vol. 6, no. 5, pp. 768–775, 2010.

5.      I. Ahmad, J. Tripathi, S. Manik, L. Umar, and J. Rabia, “Preliminary phytochemical studies of the miracle herb of the century, Nigella sativa L. (black seed),” Indo American Journal of Pharmaceutical Research, vol. 3, no. 4, pp. 3000–3007, 2013.

6.      A. A. Bukhari, “Sahih-ul-Bukhari,” http://quranx.com/ Search?q=Black+cumin&context=Hadith, 2018.

7.      K. Nadkarni, “Crocus sativus, Nigella sativa,” in Indian Material Medica, K. M. Nadkarni, Ed., pp. 386–411, Popular Prakashan, Bombay, India, 1976.

8.      M. Tariq, “Nigella sativa seeds: folklore treatment in modern day medicine,” Saudi Journal of Gastroenterology, vol. 14, no. 3, pp. 105-106, 2008.

9.      Datta, A. K. and Saha, A. 2003. Cytomorphological Studies and Seed Protein Characterization of Nigella sativa L. and Nigella damascena L. Cytologia 68: 51-60.

10.  CD - Agriculture and Environment Education/32- Condiments & Spices Production (CSPS)/Black Cumin-255.

11.  Larrousse L. 2007. Larrousse’s Gastronomiqué. Cold Spring Harbour Press, Paris France. pp 1068 – 1070.

12.  Al-Jassir MS. Chemical composition and microflora of black cumin (Nigella sativa L.) seeds growing in Saudi Arabia. Food Chem 1992; 45:239-242.

13.  Cheikh-Rouhou S, Besbes S, Lognay G, Blecker C, Deroanne C, Attia H. Sterol composition of black cumin (Nigella sativa L.) and Aleppo pine (Pinus halpensis Mill.) seed oils, J Food Comp Anal. 2008; 21(2):162-168.

14.  Bourgou S, Ksouri R, Bellila A, Skandrani I, Falleh H, Marzouk B. Phenolic composition and biological activities of Tunisian Nigella sativa L. shoots and roots. C R Biol 2008; 331(1):48-55.

15.  Nickavar B, Mojab F, Javidnia K, Amoli MA. Chemic al composition of the fixed and volatile oils of Nigella sativa L. from Iran. Z Naturforsch 2003; 58(9-10):629-631.

16.  Mehta BK, Pandit V, Gupta M. New principles from seeds of Nigella sativa. Nat Prod Res 2009; 23(2):138-48.

17.  Al-Ali A, Alkhawajah AA, Randhawa MA, Shaikh NA. Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J Ayub Med Coll Abbottabad. 2008; 20(2):25-27.

18.  Yarnell E, Abascal K. Nigella sativa holy herb of the Middle East. Altern Compl Therap 2011; 17(2):99-105.

19.  Morsi NM. Antimicrobial effect of crude extracts of Nigella sativa on multiple antibiotics-resistant bacteria. Acta Microbiol Pol 2000; 49(1):63-74.

20.  Hannan A, Saleem S, Chaudhary S, Barka M, Arshad MU. Anti-bacterial activity of Nigella sativa against clinicalisolates of methicillin resistant Staphylococcus aureus. J Ayub Med Coll Abbottabad. 2008; 20(3):72-74.

21.  Salem EM, Yar T, Bamosa AO, Al-Quorain A, Yasawy MI, Alsulaiman RM et al. Comparative study of Nigella sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia. Saudi J Gastroenterol. 2010; 16(3):207-214.

22.  Bita A, Rosu AF, Calina D, Rosu L, Zlatian O, Dindere C et al. An alternative treatment for Candida infections with Nigella sativa extracts. Eur J Hosp Pharm. 2012; 19:162.

23.  Aljabre SH, Randhawa MA, Akhtar N, Alakloby OM, Alqurashi AM, Aldossary A. Antidermatophyte activity of ether extract of Nigella sativa and its active principle, thymoquinone. J Ethnopharm. 2005; 101:116-119.

24.  Nemmar A, Al-Salam S, Zia S, Marzouqi F, Al-Dhaheri A, Subramaniyan D et al. Contrasting actions of diesel exhaust particles on the pulmonary and cardiovascular systems and the effects of thymoquinone. Br J Pharmacol. 2011; 164(7):1871-1882.

25.  Mbarek A, Elabbadi N, Bensalah M, Gamouh A, Aboufatima, Benharref, et al. Anti-tumor properties of blackseed (Nigella sativa L.) extracts, Brazilian Journal of Medical and Biological Research. 2007; 40:839-847.

 

 

 

Related Images:



Recent Images



Neurological Complications among Pregnant and Post Partum Mothers in a Private Hospital, Yogyakarta, Indonesia
Review on Regulatory Affairs in Pharmaceutical Industry
Cucumber and Mint Soap: Preparation and Evaluation
Topical Delivery in Cosmetics: Enhancing Penetration and Bioavailability
Formulation and Evaluation of Polyherbal Soap
Gelatin: A Widely Used Pharmaceutical Excipient
Therapeutic insights into Saroglitazar: a dual PPAR- α/γ agonist targeting diabetic dyslipidaemia and NAFLD
A Comprehensive Review on Dyslipidemia and Obesity: Pathophysiology, Clinical Implications and Management Approaches
Antidiabetic Herbs and Polyherbal Antidiabetic Formulations –An Overview
Review on Clinical Research and Clinical Trials

Tags